India Glycols Limited · NSE:INDIAGLYCO

India Glycols — Q3 FY22 Earnings Presentation

43 slides from India Glycols's earnings presentation, Feb 15, 2022

  1. Slide 1: Regulation 30 cover letter to stock exchanges

    0 ~ cE.RTt,i;-;. .<...<,,) ('"1',,_ ~ '6 t \\?~y) ISO 9001 INDIA GLYCOLS LIMITED·· ISO 14001 ; ISO 45001 ; ISO 50001 Plot No. 2-8, Sector -126, NOIDA-201304, Distt. Gautam Budh Nagar, Uttar Pradesh, Tel.: +91 120 6860000, 3090100, 3090200 Fax : +91 120 3090111, 3090211 E-mail : iglho@indiaglycols.co

  2. Slide 2: India Glycols Limited Investor Presentation Q3 & 9M FY22

    India Glycols Limited Investor Presentation Q3 & 9M FY22

  3. Slide 3: Safe Harbour Statement

    Safe Harbour Statement This presentation may contain statements which reflect the management’s current views and estimates and could be construed as forward-looking statements. These statements are based on certain assumptions and expectations of future events. The company cannot guarantee that thes

  4. Slide 4: Note on JV Transaction

    Note on JV Transaction The Board of Directors of the parent Company at their meeting held on 24th June, 2020 had considered and approved transfer of parent Company’s BioEO (Speciality Chemicals) Business to a wholly-owned subsidiary, which was further approved by the members of the parent Company at

  5. Slide 5: Q3 & 9M FY22 Performance

    re INDIA GLYCOLS LIMITED

  6. Slide 6: Performance Overview, Highlights, Feedstock Trends, Financials

    Performance Overview Highlights Feedstock Trends Financials .

  7. Slide 7: Performance Overview – Q3FY22 vs Q3FY21

    Performance Overview – Q3FY22 vs Q3FY21 Gross Turnover Net Turnover EBIDTA 1,760 Cr 795 Cr 62 Cr + 4% - 11 % - 36 % EBIDTA Margin PAT 24 Cr 7.74% + 20% Growth momentum continued despite the following factors • EOD business transfer to JV • Shutdown in December • Unprecedented escalations in feedstoc

  8. Slide 8: Performance Overview – Q3FY22 vs Q3FY21 – Continued Business

    Performance Overview – Q3FY22 vs Q3FY21 – Continued Business Gross Turnover Net Turnover EBIDTA 1,760 Cr 795 Cr 62 Cr +7% +12% -11% EBIDTA Margin PAT 7.74% 24 Cr + 34% Excellent performance for continued businesses • EO Sales now part of IGL sales • EODs and formulated products part of the JV sales

  9. Slide 9: Performance Overview – 9MFY22 vs 9MFY21

    Performance Overview – 9MFY22 vs 9MFY21 Gross Turnover Net Turnover EBIDTA 5,321 Cr 2,440 Cr 214 Cr + 25% + 21% -11% PAT EBIDTA Margin 273 Cr * 8.77% + 350% Resilient performance for first 9 months on the back of good bounce back in BSPC and good growth in PS and despite shutdown and unprecedented e

  10. Slide 10: Performance Overview – 9MFY22 vs 9MFY21 – Continued Business

    Performance Overview – 9MFY22 vs 9MFY21- Continued Business Gross Turnover Net Turnover EBIDTA 5,107 Cr 2,226 Cr 192Cr + 34% + 42% + 3% PAT EBIDTA Margin 263 Cr * 8.63% 489% Company did well for the first 9 months of FY22 on the back of good volume trajectory across its business verticals. Feedstock

  11. Slide 11: Performance Overview - Highlights

    Performance Overview - Highlights • Plant Shutdown and Catalyst Changeover completed in December Bio-based • Unprecedented escalation in Feedstock and Energy prices putting substantial Specialties pressure on margins & Performance Chemicals • Grain based bio-ethanol projects in progress – expected c

  12. Slide 12: Feedstock Factors and Trends

    Feedstock Factors and Trends Global Energy Crisis Demand Surge Bio-based Coal Shortage Ingredients Climatic Changes Sustainability & Green transition Commodity Prices India Glycols Limited, Investor Presentation December 2021

  13. Slide 13: Feedstock Trends

    Feedstock Trends 250 200 150 100 50 0 Steel Coal Ethanol Acetic A Dec-21 Dec-22

  14. Slide 14: Trends – Bioethanol and Corn

    Trends – Bioethanol and Corn Manuf. Imported Ethanol Corn • Prices increased sharply from mid 2021 from $ 1.4 /gallon to $ 3.2 /gallon in Nov 2021 • Prices and forecasts in near term continue to hold strong • IGL landed prices have been significantly lower than spot prices due to contracts and plann

  15. Slide 15: Bioethanol Scenario

    Bioethanol Scenario US in the largest producer and consumer US & Brazil produce 84% of global ethanol Nearly 70% of BE export is from the US Nearly all US BE is corn based 51% of US exports are to Canada, Brazil and India

  16. Slide 16: Bio-ethanol Scenario

    Bio-ethanol Scenario • Softening from peak but prices still holding strong, expected to be supported for near term Crude Price • Fears that Ukraine invasion could curb exports – one of the largest exporters of wheat and corn Corn, Soy, Sugar, Palm Oil, Canola • Rising Crude prices means increased bl

  17. Slide 17: Financial Summary

    Financial Summary Particulars (In INR Cr) Q3FY22 Q3FY21 Y-o-Y (%) 9MFY22 9MFY21 Y-o-Y (%) Revenue from operations (net of excise) 795 712 11.7% 2,226 1,565 42.2% • Bounce back in Other Income 7 1 380.8% 17 5 226.3% BSPC both in sales Total Income 802 713 12.5% 2,243 1,570 42.8% Cost of Material Cons

  18. Slide 18: Segment-wise Net Revenue

    Segment-wise Net Revenue Q3FY22 Q3FY21 4% 6% 22% 23% 71% 74% Bio-based Specialities and Performance Chemicals Potable Spirits 9MFY22 9MFY21 5% 7% Ennature Biopharma 23% 28% 65% 72% India Glycols Limited, Investor Presentation December 2021

  19. Slide 19: Segment Performance & Key Ratios

    Segment Performance & Key Ratios (In INR Crs) Q3FY22 Q3FY21 % Change 9MFY22 9MFY21 % YoY Bio-based Specialities and Performance Chemicals Net Revenue 587 505 16% 1,597 1,012 58% EBIT 24 10 136% 77 20 280% % margin 4.2% 2.0% 211bps 4.8% 2.0% 282bps Potable Spirits Net Revenue 175 163 8% 510 440 16% E

  20. Slide 20: Company Overview

    re INDIA GLYCOLS LIMITED

  21. Slide 21: IGL at a glance

    IGL at a glance Diversified portfolio with synergies – Bio-based Specialties, Bio-Polymers, Plant Global customer base and partnerships based APIs & Nutraceuticals, Potable with reputed global companies Spirits, Gases, Bio Fuels, CarbonSmart range First company in the world to use innovative green t

  22. Slide 22: Portfolio: Sustainable bio-based ingredients based on green technologies

    Portfolio: Sustainable bio-based ingredients based on green technologies Bio-Based Specialities Potable Spirits Nutraceuticals IGL Green JV Unique strength in Bio Ethanol, IMFL, Branded Country Liquor, ENA Expertise in green extraction - Returns through 49% in JV Glycols, EO, Ethers-multi feedstock

  23. Slide 23: Our History in Major Milestones

    Our History in Major Milestones 1988 1994 1996 2001 2004 2006 2008 2010 2015 2020 2021 First EO Formulation Guar Gum 1 ENA Glycol E 2 MEG Dehradun Guar Gum Sanitizers JV Distillery Purification Sulphation Glycol E 1 Textile 600 TPD Ennature PO Clariant Guar Gum 1 1 3 5 6 8 10 13 14 16 18 19 1988 199

  24. Slide 24: Catering to diverse end markets

    Catering to diverse end markets • Glycols are used for the manufacture of polyester yarn, fibre, film and resin and as an automobile coolant • Bio-glycols cater to the beverage and food industry's packaging requirement of PET bottles and polyester film • Ethyl / Butyl glycol ethers and its acetates,

  25. Slide 25: IGL entered into a 49:51 JV with Clariant…

    IGL entered into a 49:51 JV with Clariant… • IGL carved out its Bio-EO based ethoxylates Promoters Public and derivatives business to a subsidiary 61.01% 1 38.99% 1 ‘Clariant IGL Specialty Chemicals Pvt. Ltd’. & 1 - Shareholding as on 30th June 2021 inducted Clariant as 51% JV partner • Both compani

  26. Slide 26: … JV to become one of the leaders in bio-based ethoxylates and derivatives

    … JV to become one of the leaders in bio-based ethoxylates and derivatives By combining production and distribution capacity, the joint venture is expected to become a leading supplier of renewable materials to the rapidly growing consumer care market in India and neighbouring countries Production f

  27. Slide 27: A value-generating combination with Clariant

    A value-generating combination with Clariant Chairman, Mr U.S. Bhartia’s thoughts on the • The JV combines IGL’s renewable bio-ethylene oxide derivatives business, deal: which includes a multipurpose production facility including an alkoxylation plant located in Kashipur, Uttarakhand, with Clariant’

  28. Slide 28: Operations – key locations

    Operations – key locations Kashipur Dehradun Noida HO Gorakhpur India Glycols Limited, Investor Presentation December 2021

  29. Slide 29: Leveraging synergies to create value–integrated manufacturing for bio-based products

    Leveraging synergies to create value–integrated manufacturing for bio-based products Power O2, N2, Ar ENA Liquor Sanitizers IGD Alcohol Grain Ind Gr. CO2 Distillery O2 ASU EO-CO2 mix Bio- Bio- Green Bio- Molasses Distillery Ethylene Bio-E O EODs Performance Ethanol Chemicals CarbonSmart- Ethylene CS

  30. Slide 30: Manufacturing Capabilities

    Manufacturing Capabilities Kashipur Site Gorakhpur Site 300-acre state of art integrated manufacturing complex 56-acre state of art distillation and bottling complex located in Uttarakhand, India Fermentation Fermentation Ethanol Distillation Ethanol Distillation Ethanol Extra Purification Ethanol E

  31. Slide 31: R&D: Creating value through New Product Development; focus on Green Chemistry

    R&D: Creating value through New Product Development; focus on Green Chemistry • R&D focuses on NPD, designing products for the future • DSIR Recognized R&D - Dehradun and Kashipur • Green Chemistry, renewable resources stat-of-art of Processes & Performance-Oriented products: o Green Solvents for In

  32. Slide 32: Market-led innovations in product, process and application technologies

    Market-led innovations in product, process and application technologies • Continuously working for: • Maintaining novelty, uniqueness and Technical edge of products • Value creation through Novel approaches of manoeuvring different Chemistries • Value addition through structure activity correlation

  33. Slide 33: Growth drivers

    Growth drivers • High prospects of growth of industry sectors being serviced by IGL – Personal Care, Automotive, Packaging, Beverages, Oil & Gas, Home Care, Pharma, Nutraceuticals etc, Textiles – most expected to grow at near double digit or more • Increasing consumer awareness and demand for sustai

  34. Slide 34: 5-year Financial Trajectory

    5-year Financial Trajectory In INR Cr unless specified Gross Revenue Net Revenue EBITDA 3,356 3,470 436 6,058 2,948 403 5,951 3,028 359 5,117 335 2,473 3,583 4,155 243 2017 2018 2019 2020 2021 2017 2018 2019 2020 2021 2017 2018 2019 2020 2021 EBITDA Margin (%) PAT Cash Profit 13.0% 256 238 233 11.6%

  35. Slide 35: 5-year Key Ratios

    5-year Key Ratios Ratios 2017 2018 2019 2020 2021 Asset Turn Over Ratio 1.07 1.24 1.38 1.48 1.49 Current Ratio 0.63 0.71 0.88 0.87 1.00 Quick Ratio 0.34 0.43 0.48 0.51 0.58 Debt to Equity Ratio 1.07 0.75 0.77 0.70 0.76 Interest Coverage Ratio 2.00 2.85 3.22 2.95 3.21 Capital Employed Turnover Ratio

  36. Slide 36: Sustainability, ESG

    Sustainability, ESG Environment Stewardship • World’s first company to produce Bio-Based EO and its derivatives • Largest producer of Bio-based EO and its derivatives • Next Generation CarbonSmart products from emissions (fossil carbon) - collaboration with LanzaTech & consumer majors like UL and Lu

  37. Slide 37: Sustainability, ESG

    Sustainability, ESG Management & Ethical System Certifications – sustaining for over a decade 1. ISO 9001:2015 Quality Management 2. ISO 14001: 2015 Environmental Management 3. ISO 45001 : 2018 Occupational Health & Safety Management 4. ISO 50001:2018 Energy Management 5. SA 8000: 2014 Social Accoun

  38. Slide 38: Business Structure, Holdings

    Business Structure, Holdings • Kashipur Holdings Limited, the Promoter, holds 38.14% shareholding of Holding India Glycols Limited Company • Promoter/Promoter Group holds 61.01% shareholding • Shakumbari Sugar and Allied Industries Limited Indian • IGL Finance Limited subsidiaries • IGL Chemicals an

  39. Slide 39: Board of Directors

    Board of Directors Executive Directors Non-Executive Directors Non-Independent Director: Mr. U. S. Bhartia, Chairman & Managing Director Mrs. Jayshree Bhartia Independent Directors: Mr. Pradip Kumar Khaitan Ms. Pragya Bhartia Barwale Mr. Ravi Jhunjhunwala Mr. Jitender Balakrishnan Mr. Jagmohan N. Ke

  40. Slide 40: Leadership team

    Leadership team Mr. Rupark Mr. Anand Prof. Dr. R.K. Mr. Sanjeev Mr. S.K. Shukla, Mr. Ankur Jain, Mr. Shrinivas Sarswat, Singhal, Khandal, Gurwara, Dusi, Head – Liquor Head (Legal) & Chief Executive Chief Financial President - R&D President Business Company Chief Human Officer Officer and Business Ma

  41. Slide 41: Shareholding pattern: as on 31st December 2021

    Shareholding pattern: as on 31st December 2021 Others, Shareholder Information as on 31st December 2021 Individual 1.23% Public Shareholding, BSE Ticker 500201 25.41% NSE Symbol INDIAGLYCO FPIs/FIIs/NRI Market Cap (in ₹ Cr) 2,812 s/OCBs, 3.28% % Free-Float 38.99% Free-Float Market Cap (in INR Cr) 1,

  42. Slide 42: India Glycols Limited contact details

    India Glycols Limited CIN: L24111UR1983PLC009097 Ankur Jain Company Secretary & Compliance Officer Head office 2B, Sector-126, Noida Gautam Budh Nagar Uttar Pradesh 201304 Tel: +91-120-6860000, 3090100, 3090200 Fax: +91-120-3090111 Email: investor.relations@indiaglycols.com

  43. Slide 43: Thank you

    is] INDIA GLYCOLS LIMITED YL Thank you

India Glycols — Q3 FY22 Earnings Presentation on 6ix